🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementHypoglycemia risk with concomitant sulfonylurea use — my results so far Page 5

Hypoglycemia risk with concomitant sulfonylurea use — my results so far

mike.trainer_LA Mon, Jan 8, 2024 at 5:38 PM 34 replies 2,155 viewsPage 5 of 7
JessicaH_TX
Senior Member
4,123
13,456
Dec 2023
Houston, TX
Jan 9, 2024 at 12:43 AM#21

Congrats mike.trainer_LA!! Keep going — you're doing incredible. 🎉

25 16wendy_avl, jason_paloalto, Dr.LeslieOBGYN and 22 others
Reply Quote Save Share Report
RickReta_CO
Member
312
1,234
Jan 2025
Colorado
Jan 9, 2024 at 1:00 AM#22

Reading this thread on Hypoglycemia risk with hits close to home. Night shift nurse — I started at 287 lbs and felt like I would tried everything.

13 months on tirz and I am a different person. Not just the 62 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Hypoglycemia risk — take the leap. It was the best health decision I have ever made. ❤️

Last edited: Jan 9, 2024 at 6:00 AM
19 6jim_asheville, matt_MKE, Dr.ReproEndo and 16 others
Reply Quote Save Share Report
Dr.ObesityMed
VIP Member
3,456
19,234
Nov 2023
Denver, CO
Online
Jan 9, 2024 at 1:17 AM#23

As a pharmacist, I want to add some clinical context to this discussion on Hypoglycemia risk with concomitant.

Building on what JessicaH_TX said — the evidence base here is robust. The key publications to reference are from the SELECT program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
36 11SurmountFan_IN, PeptideChemSF, A1cHero_PHX and 33 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
pete_nash
Member
312
1,345
Aug 2024
Nashville, TN
Jan 9, 2024 at 1:34 AM#24

RickReta_CO — wow. I've been looking for this exact info for weeks.

Last edited: Jan 9, 2024 at 7:34 AM
35 16SarahChen_PharmD, sarah.morrison, NeuroNate and 32 others
Reply Quote Save Share Report
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
Jan 9, 2024 at 1:51 AM#25

Adding my data to this Hypoglycemia risk with discussion:

MetricBaselineMonth 5Month 6
Weight240 lbs245 lbs215 lbs
A1C6.4%6.0%5.2%
hsCRP4.04.00.6

Protocol: Semaglutide 1.7mg/wk, resistance training 3x/wk, protein 1.2g/kg/day.

22 18SaraMom3, Dr.MetabolicMD, RetaRick_CA and 19 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register